Cargando…

Evidence for a personalized early start of norepinephrine in septic shock

During septic shock, vasopressor infusion is usually started only after having corrected the hypovolaemic component of circulatory failure, even in the most severe patients. However, earlier administration of norepinephrine, simultaneously with fluid resuscitation, should be considered in some cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Monnet, Xavier, Lai, Christopher, Ospina-Tascon, Gustavo, De Backer, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464210/
https://www.ncbi.nlm.nih.gov/pubmed/37608327
http://dx.doi.org/10.1186/s13054-023-04593-5
_version_ 1785098416442834944
author Monnet, Xavier
Lai, Christopher
Ospina-Tascon, Gustavo
De Backer, Daniel
author_facet Monnet, Xavier
Lai, Christopher
Ospina-Tascon, Gustavo
De Backer, Daniel
author_sort Monnet, Xavier
collection PubMed
description During septic shock, vasopressor infusion is usually started only after having corrected the hypovolaemic component of circulatory failure, even in the most severe patients. However, earlier administration of norepinephrine, simultaneously with fluid resuscitation, should be considered in some cases. Duration and depth of hypotension strongly worsen outcomes in septic shock patients. However, the response of arterial pressure to volume expansion is inconstant, delayed, and transitory. In the case of profound, life-threatening hypotension, relying only on fluids to restore blood pressure may unduly prolong hypotension and organ hypoperfusion. Conversely, norepinephrine rapidly increases and better stabilizes arterial pressure. By binding venous adrenergic receptors, it transforms part of the unstressed blood volume into stressed blood volume. It increases the mean systemic filling pressure and increases the fluid-induced increase in mean systemic filling pressure, as observed in septic shock patients. This may improve end-organ perfusion, as shown by some animal studies. Two observational studies comparing early vs. later administration of norepinephrine in septic shock patients using a propensity score showed that early administration reduced the administered fluid volume and day-28 mortality. Conversely, in another propensity score-based study, norepinephrine administration within the first hour following shock diagnosis increased day-28 mortality. The only randomized controlled study that compared the early administration of norepinephrine alone to a placebo showed that the early continuous administration of norepinephrine at a fixed dose of 0.05 µg/kg/min, with norepinephrine added in open label, showed that shock control was achieved more often than in the placebo group. The choice of starting norepinephrine administration early should be adapted to the patient’s condition. Logically, it should first be addressed to patients with profound hypotension, when the arterial tone is very low, as suggested by a low diastolic blood pressure (e.g. ≤ 40 mmHg), or by a high diastolic shock index (heart rate/diastolic blood pressure) (e.g. ≥ 3). Early administration of norepinephrine should also be considered in patients in whom fluid accumulation is likely to occur or in whom fluid accumulation would be particularly deleterious (in case of acute respiratory distress syndrome or intra-abdominal hypertension for example). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04593-5.
format Online
Article
Text
id pubmed-10464210
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104642102023-08-30 Evidence for a personalized early start of norepinephrine in septic shock Monnet, Xavier Lai, Christopher Ospina-Tascon, Gustavo De Backer, Daniel Crit Care Comment During septic shock, vasopressor infusion is usually started only after having corrected the hypovolaemic component of circulatory failure, even in the most severe patients. However, earlier administration of norepinephrine, simultaneously with fluid resuscitation, should be considered in some cases. Duration and depth of hypotension strongly worsen outcomes in septic shock patients. However, the response of arterial pressure to volume expansion is inconstant, delayed, and transitory. In the case of profound, life-threatening hypotension, relying only on fluids to restore blood pressure may unduly prolong hypotension and organ hypoperfusion. Conversely, norepinephrine rapidly increases and better stabilizes arterial pressure. By binding venous adrenergic receptors, it transforms part of the unstressed blood volume into stressed blood volume. It increases the mean systemic filling pressure and increases the fluid-induced increase in mean systemic filling pressure, as observed in septic shock patients. This may improve end-organ perfusion, as shown by some animal studies. Two observational studies comparing early vs. later administration of norepinephrine in septic shock patients using a propensity score showed that early administration reduced the administered fluid volume and day-28 mortality. Conversely, in another propensity score-based study, norepinephrine administration within the first hour following shock diagnosis increased day-28 mortality. The only randomized controlled study that compared the early administration of norepinephrine alone to a placebo showed that the early continuous administration of norepinephrine at a fixed dose of 0.05 µg/kg/min, with norepinephrine added in open label, showed that shock control was achieved more often than in the placebo group. The choice of starting norepinephrine administration early should be adapted to the patient’s condition. Logically, it should first be addressed to patients with profound hypotension, when the arterial tone is very low, as suggested by a low diastolic blood pressure (e.g. ≤ 40 mmHg), or by a high diastolic shock index (heart rate/diastolic blood pressure) (e.g. ≥ 3). Early administration of norepinephrine should also be considered in patients in whom fluid accumulation is likely to occur or in whom fluid accumulation would be particularly deleterious (in case of acute respiratory distress syndrome or intra-abdominal hypertension for example). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04593-5. BioMed Central 2023-08-22 /pmc/articles/PMC10464210/ /pubmed/37608327 http://dx.doi.org/10.1186/s13054-023-04593-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Monnet, Xavier
Lai, Christopher
Ospina-Tascon, Gustavo
De Backer, Daniel
Evidence for a personalized early start of norepinephrine in septic shock
title Evidence for a personalized early start of norepinephrine in septic shock
title_full Evidence for a personalized early start of norepinephrine in septic shock
title_fullStr Evidence for a personalized early start of norepinephrine in septic shock
title_full_unstemmed Evidence for a personalized early start of norepinephrine in septic shock
title_short Evidence for a personalized early start of norepinephrine in septic shock
title_sort evidence for a personalized early start of norepinephrine in septic shock
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464210/
https://www.ncbi.nlm.nih.gov/pubmed/37608327
http://dx.doi.org/10.1186/s13054-023-04593-5
work_keys_str_mv AT monnetxavier evidenceforapersonalizedearlystartofnorepinephrineinsepticshock
AT laichristopher evidenceforapersonalizedearlystartofnorepinephrineinsepticshock
AT ospinatascongustavo evidenceforapersonalizedearlystartofnorepinephrineinsepticshock
AT debackerdaniel evidenceforapersonalizedearlystartofnorepinephrineinsepticshock